How should phenytoin (Dilantin) toxicity be managed?

Management of Phenytoin (Dilantin) Toxicity

The primary treatment for phenytoin toxicity is supportive care with discontinuation of the drug, as there is no specific antidote. 1

Immediate Management Steps

Discontinue Phenytoin

• Stop phenytoin administration immediately upon recognition of toxicity 2
• Recognize that phenytoin exhibits zero-order (saturation) kinetics in overdose, resulting in a greatly prolonged half-life (40-100 hours) and extended duration of symptoms 1, 3

Supportive Care (Mainstay of Treatment)

Vital function support:

• Airway protection if altered mental status is severe
• Cardiac monitoring for arrhythmias and hypotension (rare with oral ingestion but can occur with IV administration) 2, 1
• Monitor for and treat bradycardia or cardiac arrest if they occur 2

Symptom management:

• Control nausea and vomiting
• Prevent injuries from confusion, ataxia, and nystagmus 1
• Manage seizures if they occur paradoxically (rare but reported in severe cases) 1

Clinical Monitoring

Monitor for toxicity manifestations:

• CNS effects: Confusion, nystagmus, ataxia, depressed consciousness, coma 1
• Cardiovascular: Arrhythmias, hypotension (primarily with IV administration) 2, 1
• GI symptoms: Nausea, vomiting 1

Gastrointestinal Decontamination

Activated charcoal may be considered if presentation is early (within 1-2 hours of ingestion), though evidence for benefit is limited 1. A single dose is reasonable; however, multiple-dose activated charcoal remains controversial - while experimental studies show increased clearance rates, this has not translated into proven clinical benefit 1.

One case report demonstrated successful use of repeated activated charcoal over 2 days with symptom resolution 4, but this is not standard practice.

Enhanced Elimination Techniques

Standard Approach

There is no evidence that invasive methods of enhanced elimination improve outcomes in typical cases 1. Methods like plasmapheresis, hemodialysis, or hemoperfusion have not been shown to provide clinical benefit in most situations 1.

Severe Toxicity Exception

For severe, life-threatening toxicity (levels >60-70 mg/L with significant clinical deterioration), consider hemodialysis or hemoperfusion:

• Intermittent hemodialysis has been shown in case reports to reduce phenytoin levels by approximately 27% in a single 4-hour session 5
• Combination hemoperfusion with activated charcoal plus high-flux hemodialysis reduced half-life to 7-13 hours (compared to native 40-100 hours) in severe IV overdose 3
• These interventions should be reserved for severe cases with peak levels >60-70 mg/L and significant clinical toxicity, particularly following IV overdose 5, 3

Ancillary Treatments (Limited Evidence)

The following have been attempted in case reports but lack robust evidence:

• Albumin boluses (to increase protein binding)
• Phenobarbital administration
• Intravenous lipid emulsion
• Folic acid supplementation 6

These should not be considered standard therapy.

Special Considerations

Genetic Factors

If toxicity occurs at therapeutic doses without drug interactions, suspect CYP2C9 polymorphism (particularly *3/*3 homozygous mutation), which reduces phenytoin metabolism by 50% 4. This is rare in most populations but should be considered when toxicity is unexplained.

Drug Interactions

Review all medications for interactions, particularly:

• Omeprazole and other CYP2C9 inhibitors 4
• Other enzyme inhibitors that may elevate phenytoin levels 2

Monitoring

• Check phenytoin levels immediately if CNS toxicity develops 2
• In patients with renal/hepatic disease or hypoalbuminemia, monitor free (unbound) phenytoin levels rather than total levels 2
• Serial levels help track elimination, but remember the prolonged half-life means levels may remain elevated for days to weeks 1

Key Pitfalls to Avoid

• Do not assume rapid clearance: Zero-order kinetics means prolonged hospitalization may be necessary
• Do not routinely use invasive elimination techniques: Reserve for truly severe cases only
• Do not overlook cardiac monitoring: Though rare with oral ingestion, cardiac complications can occur
• Do not miss underlying causes: Search for treatable precipitants like drug interactions or genetic polymorphisms 4

Expected Clinical Course

Deaths are unlikely after phenytoin intoxication alone 1. Most patients recover with supportive care, though the prolonged half-life in overdose can result in extended hospitalization and risk of complications from immobility and altered mental status 1.